Tyra Biosciences, Inc. Annual Operating Income (Loss) in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Tyra Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2024.
  • Tyra Biosciences, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$29.7M, a 15.9% decline year-over-year.
  • Tyra Biosciences, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$104M, a 30.3% decline year-over-year.
  • Tyra Biosciences, Inc. annual Operating Income (Loss) for 2024 was -$104M, a 30.3% decline from 2023.
  • Tyra Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$79.9M, a 35.7% decline from 2022.
  • Tyra Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$58.9M, a 124% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$104M -$24.2M -30.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-27
2023 -$79.9M -$21M -35.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-27
2022 -$58.9M -$32.6M -124% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 -$26.3M -$17M -183% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 -$9.3M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.